Literature DB >> 2819792

Synaptic transmission in ammonia intoxication.

W Raabe.   

Abstract

Ammonia intoxication allegedly plays a significant role in the pathophysiology of hepatic encephalopathy. In order to understand the pathogenesis of this encephalopathy it is necessary to know the effects of ammonia on the mechanisms by which neurons communicate, i.e., excitatory and inhibitory synaptic transmissions. NH4+ decreases excitatory synaptic transmission mediated by glutamate. Possibly, this effect is related to a depletion of glutamate in presynaptic terminals. NH4+ decreases inhibitory synaptic transmission mediated by hyperpolarizing Cl(-)-dependent inhibitory postsynaptic potentials. This effect is related to the inactivation of the extrusion of Cl- from neurons by NH4+. By the very same action, NH4+ also decreases the hyperpolarizing action of Ca2+- and voltage-dependent Cl- currents. These currents may modify the efficacy of the synaptic input to neurons and increase neuronal excitability. Estimates derived from experimental observations suggest that an increase of CNS tissue NH4+ to 0.5 mumol/g is sufficient to disturb excitatory and inhibitory synaptic transmission and to initiate the encephalopathy related to acute ammonia intoxication. Chronic portasystemic shunting of blood, as in hepatic encephalopathy, significantly changes the relation between CNS NH4+ and function of synaptic transmission. A portacaval shunt increases the tissue NH4+ necessary to disturb synaptic transmission. However, after a portasystemic shunt, synaptic transmission becomes extremely sensitive to any acute increase of NH4+ in the CNS.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2819792     DOI: 10.1007/BF02833604

Source DB:  PubMed          Journal:  Neurochem Pathol        ISSN: 0734-600X


  17 in total

Review 1.  Proton magnetic resonance spectroscopy in portal-systemic encephalopathy.

Authors:  H Köstler
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

Review 2.  Neurochemistry of hepatic encephalopathy.

Authors:  C O Record
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

3.  Portacaval anastomosis results in more widespread alterations of cerebral metabolism in old versus young adult rats: implications for post-shunt encephalopathy.

Authors:  R M Audet; R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-03       Impact factor: 3.584

Review 4.  Cerebral energy metabolism in hepatic encephalopathy and hyperammonemia.

Authors:  K V Rao; M D Norenberg
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

Review 5.  Is ammonia a pathogenetic factor in Alzheimer's disease?

Authors:  N Seiler
Journal:  Neurochem Res       Date:  1993-03       Impact factor: 3.996

6.  In Silico Preliminary Association of Ammonia Metabolism Genes GLS, CPS1, and GLUL with Risk of Alzheimer's Disease, Major Depressive Disorder, and Type 2 Diabetes.

Authors:  Jeddidiah W D Griffin; Ying Liu; Patrick C Bradshaw; Kesheng Wang
Journal:  J Mol Neurosci       Date:  2018-02-13       Impact factor: 3.444

Review 7.  Acute metabolic encephalopathy: a review of causes, mechanisms and treatment.

Authors:  R Surtees; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

8.  Neuronal and glial marker proteins in encephalopathy associated with acute liver failure and acute hyperammonemia in the rabbit.

Authors:  M Groeneweg; R J de Knegt; A Hamberger; M Ding; S Wang; S W Schalm; K G Haglid
Journal:  Metab Brain Dis       Date:  1993-06       Impact factor: 3.584

Review 9.  Ammonia neurotoxicity: role of the mitochondrial permeability transition.

Authors:  K V Rama Rao; A R Jayakumar; D M Norenberg
Journal:  Metab Brain Dis       Date:  2003-06       Impact factor: 3.584

10.  Hepatic encephalopathy influences high-affinity uptake of transmitter glutamate and aspartate into the hippocampal formation.

Authors:  W Schmidt; G Wolf; K Grüngreiff; M Meier; T Reum
Journal:  Metab Brain Dis       Date:  1990-03       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.